Minhtam S Nguyen, MD
Family Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Nguyen’s office at (408) 993-8536 to ask if they take your plan before you enroll.
California Medical Board record
Licence A45479 · Current
Licensed to practise in California · since 1988 · expires 2027-12-31 · University Rene Descartes (Paris V) U.F.R. of Medicine Cochin-Port Royal.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$4,542 in 2021
Medicaid paid $4,542 for 432 billed services this clinician did in 2021, up to 78 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 78 | $2,067 |
| Pure tone audiometry (threshold); air only | 80 | $1,190 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 12 | $665 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 14 | $619 |
| Short return visit | 28 | $2 |
| Short return visit (20+ min) | 16 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 108 | $0 |
| Unlisted preventive medicine service | 96 | $0 |
| 2021 | 432 | 8 | 78 | $4,542 |
| 2020 | 1,394 | 7 | 134 | $8,217 |
| 2019 | 1,716 | 7 | 81 | $9,087 |
| 2018 | 1,852 | 9 | 120 | $13,022 |
See the largest Medicaid services in earlier years
2020
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 269 | $5,340 |
| Pure tone audiometry (threshold); air only | 108 | $1,705 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 27 | $1,073 |
| Short return visit | 417 | $51 |
| Short return visit (20+ min) | 343 | $48 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 99 | $0 |
| Unlisted preventive medicine service | 131 | $0 |
2019
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 214 | $4,370 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 39 | $3,373 |
| Pure tone audiometry (threshold); air only | 83 | $1,334 |
| Unlisted preventive medicine service | 160 | $10 |
| Short return visit | 540 | $0 |
| Short return visit (20+ min) | 590 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 90 | $0 |
2018
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 77 | $6,013 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 282 | $4,559 |
| Pure tone audiometry (threshold); air only | 135 | $2,016 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 13 | $388 |
| Unlisted preventive medicine service | 173 | $25 |
| Short return visit | 492 | $16 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 32 | $4 |
| Short return visit (20+ min) | 579 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 69 | $0 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 91 Part D prescriptions in 2022.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 91 | 36 | 0% (0) | None | $3,810 |
| 2021 | 666 | 79 | 0% (0) | 4% | $14,382 |
| 2020 | 689 | 67 | 0% (0) | None | $19,387 |
| 2019 | 605 | 54 | 0% (0) | 9% | $19,055 |
| 2018 | 404 | 46 | None | 7% | $8,303 |
| 2017 | 389 | 47 | 0% (0) | 6% | $7,304 |
| 2016 | 345 | 40 | 0% (0) | 14% | $8,558 |
| 2015 | 353 | 37 | None | 22% | $10,757 |
| 2014 | 445 | 36 | None | None | $12,533 |
| 2013 | 442 | 50 | None | 22% | $10,644 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 2 drugs
| Amlodipine Besylate | 15 | $164 | $11 |
| Lovastatin | 11 | $107 | $10 |
2021: 15 drugs
| Azelastine | 45 | $1,535 | $34 |
| Losartan | 83 | $1,162 | $14 |
| Atorvastatin | 54 | $767 | $14 |
| Metoprolol | 22 | $450 | $20 |
| Amlodipine Besylate | 63 | $450 | $7 |
| Lovastatin | 52 | $445 | $9 |
| Lisinopril | 38 | $342 | $9 |
| Triamcinolone Acetonide | 33 | $275 | $8 |
| Omeprazole | 37 | $240 | $6 |
| Benazepril | 17 | $194 | $11 |
| Fluticasone Propionate | 11 | $135 | $12 |
| Metformin Hcl Er | 20 | $113 | $6 |
| Montelukast | 18 | $104 | $6 |
| Metformin | 17 | $75 | $4 |
| Ibuprofen | 16 | $64 | $4 |
2020: 15 drugs
| Azelastine | 51 | $1,451 | $28 |
| Losartan | 87 | $1,244 | $14 |
| Atorvastatin | 51 | $581 | $11 |
| Lovastatin | 58 | $458 | $8 |
| Metoprolol | 22 | $408 | $19 |
| Amlodipine Besylate | 65 | $334 | $5 |
| Alendronate | 25 | $308 | $12 |
| Triamcinolone Acetonide | 32 | $259 | $8 |
| Lisinopril | 30 | $178 | $6 |
| Metformin | 32 | $178 | $6 |
| Omeprazole | 30 | $176 | $6 |
| Montelukast | 13 | $151 | $12 |
| Benazepril | 11 | $98 | $9 |
| Metformin Hcl Er | 13 | $62 | $5 |
| Trazodone | 17 | $44 | $3 |
2019: 15 drugs
| Azelastine | 20 | $864 | $43 |
| Lovastatin | 72 | $689 | $10 |
| Metoprolol | 25 | $647 | $26 |
| Losartan | 66 | $632 | $10 |
| Albuterol Sulfate Hfa | 13 | $551 | $42 |
| Alendronate | 32 | $395 | $12 |
| Lisinopril | 35 | $358 | $10 |
| Amlodipine Besylate | 53 | $307 | $6 |
| Atorvastatin | 26 | $281 | $11 |
| Metformin | 27 | $225 | $8 |
| Omeprazole | 23 | $210 | $9 |
| Triamcinolone Acetonide | 19 | $180 | $9 |
| Ranitidine | 12 | $71 | $6 |
| Azithromycin | 13 | $69 | $5 |
| Hydrochlorothiazide | 14 | $59 | $4 |
2018: 14 drugs
| Azelastine | 21 | $1,194 | $57 |
| Ventolin Hfa | 14 | $766 | $55 |
| Lovastatin | 44 | $479 | $11 |
| Metoprolol | 12 | $349 | $29 |
| Amlodipine Besylate | 46 | $327 | $7 |
| Losartan | 33 | $278 | $8 |
| Triamcinolone Acetonide | 19 | $201 | $11 |
| Lisinopril | 32 | $191 | $6 |
| Alendronate | 15 | $174 | $12 |
| Atorvastatin | 12 | $153 | $13 |
| Metformin | 18 | $123 | $7 |
| Benazepril | 13 | $121 | $9 |
| Azithromycin | 15 | $101 | $7 |
| Omeprazole | 13 | $43 | $3 |
2017: 13 drugs
| Azelastine | 21 | $1,025 | $49 |
| Ventolin Hfa | 11 | $586 | $53 |
| Amlodipine Besylate | 63 | $454 | $7 |
| Lovastatin | 35 | $404 | $12 |
| Alendronate | 29 | $369 | $13 |
| Benazepril | 16 | $205 | $13 |
| Lisinopril | 21 | $174 | $8 |
| Triamcinolone Acetonide | 14 | $174 | $12 |
| Metformin | 17 | $161 | $9 |
| Losartan | 16 | $142 | $9 |
| Carvedilol | 12 | $110 | $9 |
| Simvastatin | 11 | $43 | $4 |
| Hydrochlorothiazide | 12 | $28 | $2 |
2016: 9 drugs
| Ventolin Hfa | 22 | $1,141 | $52 |
| Alendronate | 35 | $355 | $10 |
| Amlodipine Besylate | 56 | $335 | $6 |
| Lovastatin | 22 | $216 | $10 |
| Triamcinolone Acetonide | 18 | $182 | $10 |
| Atenolol | 14 | $86 | $6 |
| Metformin | 12 | $73 | $6 |
| Simvastatin | 15 | $67 | $4 |
| Lisinopril | 11 | $66 | $6 |
2015: 9 drugs
| Proair Hfa | 11 | $564 | $51 |
| Alendronate | 34 | $352 | $10 |
| Amlodipine Besylate | 50 | $218 | $4 |
| Triamcinolone Acetonide | 18 | $186 | $10 |
| Lovastatin | 17 | $174 | $10 |
| Atenolol | 18 | $112 | $6 |
| Simvastatin | 11 | $99 | $9 |
| Omeprazole | 19 | $90 | $5 |
| Lisinopril | 11 | $52 | $5 |
2014: 10 drugs
| Alendronate | 45 | $715 | $16 |
| Proair Hfa | 14 | $689 | $49 |
| Amlodipine Besylate | 73 | $336 | $5 |
| Lovastatin | 24 | $251 | $10 |
| Simvastatin | 19 | $180 | $9 |
| Losartan | 17 | $157 | $9 |
| Omeprazole | 22 | $147 | $7 |
| Metformin | 20 | $113 | $6 |
| Atenolol | 22 | $104 | $5 |
| Carvedilol | 11 | $64 | $6 |
2013: 9 drugs
| Alendronate | 61 | $881 | $14 |
| Amlodipine Besylate | 77 | $688 | $9 |
| Omeprazole | 39 | $439 | $11 |
| Lovastatin | 27 | $349 | $13 |
| Triamcinolone Acetonide | 25 | $283 | $11 |
| Simvastatin | 14 | $134 | $10 |
| Benazepril | 11 | $128 | $12 |
| Atenolol | 14 | $94 | $7 |
| Meloxicam | 12 | $71 | $6 |
Money from drug and device companies
$32 in 2025
A payment is not proof that care is biased.
| Merck Sharp & Dohme | Vaxelis | $32 | 1 payment
|
See the published payment
| Merck Sharp & Dohme | Meals · 2025-04-23 | Vaxelis | $32 |
Professional record
- NPI
- 1457460354
- Licence
- CA A45479California A45479: Current · expires 2027-12-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A454790
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1340 Tully Road, Suite 309, San Jose, CA, 95122
- NPI first listed
- 2006-08-30
- NPI last updated
- 2013-09-13
This is when the NPI record was last certified, not a medical board exam.